Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca’s Arimidex Halves Breast Cancer Risk, Study Finds
AstraZeneca’s Arimidex Halves Breast Cancer Risk, Study Finds
AstraZeneca’s Arimidex Halves Breast Cancer Risk, Study Finds
Submitted by
admin
on December 17, 2013 - 8:57am
Source:
Bloomberg
News Tags:
Arimidex
AstraZeneca
breast cancer
Headline:
AstraZeneca’s Arimidex Halves Breast Cancer Risk, Study Finds
Do Not Allow Advertisers to Use My Personal information
